Benjamin Padnos
Benjamin Padnos
Send Message
Benjamin Padnos
Stop FollowingBenjamin Padnos
View as an RSS Feed
COMMENTS STATS
14 Comments
19 Likes

Xoom Zooms As First Tech IPO Of 2013 [View article]
As @Off the Radar Investor mentioned, SPDL may be interesting to investors looking at XOOM as Spindle is a younger company in a similar space. Anyone buying XOOM today is buying the company at a valuation +/- $800MM versus sub $40MM for Spindle. So, while there's obvious risk with an earlier-stage company, Seeking Alpha is all about exposing people to new ideas and interesting opportunities.
One of the reasons I'm such an advocate for "public venture capital" is that "average Joes" have access to innovative companies with large upside very early in the company's life cycle. By the time individual investors could publicly buy shares in companies like FB, ZNGA, GRPN, etc., the big gains had already been made!
Clearsign's Lies, Omissions, And One 'Bad Actor' [View article]
Furthermore, Matt, it would be nice for you to disclose who is compensating you, as well as how much, for your so-called "research." I've done my homework and have been able to identify the guys you're working with. There's a full investigation under way, and our findings will be shared with several organizations who frown on market manipulation.
Bottom line: You ought to be very careful making accusations of "scams" from that see-through glass house of yours!
Clearsign's Lies, Omissions, And One 'Bad Actor' [View article]
Now I know what a celeb feels like when slimed by a tabloid! Apparently, Mr. Berry seems to believe that if my integrity and character are impugned, then investors will believe that ClearSign Combustion Company technology is flawed. He carries his SSTP deductions to absurd conclusions as regards my involvement. My five decades of ethical professional conduct are widely acknowledged, hence, his indictment of me by distorted allegations won't work.
I cannot speak for ClearSign management, but as an early participant in their technology I can say that ClearSign technology is based on experimental fact. I can also state that my effort to establish the science basis largely explains experimental data. I summarized the basic science status before I left ClearSign in a report dated 3/7/2012.
My advice to serious investors is to not rely on specious allegations, but instead go to ClearSign management for a dose of facts and reality .
Dr. Thomas S. Hartwick
Clearsign's Lies, Omissions, And One 'Bad Actor' [View article]
I will summarize my thoughts below:
1) First and foremost, this is not a “technology scam”. ClearSign's technology is very disruptive to a multi-billion (or trillion) dollar industry, and IT WORKS.
2) Secondly, and very importantly, who’s name is on various patent applications is absolutely meaningless.
3) Third, MDB Capital is a serious, IP-focused investment bank run by very smart people who have banked multiple companies from the ground floor to billion-dollar market caps. CLIR has a shot at being their next one.
4) Please keep in mind that Matt Berry has i) never spoken with anyone at ClearSign; ii) never visited the company or seen a demonstration of the technology; iii) despite multiple invitations, he has never directly addressed his concerns with ANY of the other advisors, bankers, lawyers, etc. who he maligns; and iv) we probably do not know the full story about Berry and any compensation he’s receiving from third parties with short positions. If you look at the publicly-available “short interest” data, you’ll see that the timing of his articles – particularly the first two – coincide with the build-up of a large short position: http://bit.ly/YMvDet
5) And finally, the company is executing its plan: building out the technology platform, expanding the IP portfolio, and working toward commercial validation.
I would highly urge individuals to speak with management at CLIR and/or MDB Capital. Better yet, go visit ClearSign's headquarters and get a demonstration of the technology. That will eliminate any doubt.
Clearsign's Lies, Omissions, And One 'Bad Actor' [View article]
Noticeably absent from the "more thorough report" is any mention of ClearSign's team working on the technology and commercialization efforts, Board of Directors, its technology platform, and the market size. It's simply an attempt to create fear, uncertainty and doubt, and fundamentally misses the mark.
Clearsign's Lies, Omissions, And One 'Bad Actor' [View article]
Didn't think so.
Folks, here's what Matt Berry's analysis fundamentally misses: ClearSign's technology is hugely disruptive and IT WORKS. Who's names are on the patents isn't relevant.
Berry's research is thorough, but his thesis is wrong. All this innuendo and the personal attacks have absolutely nothing to do with the fact that CLIR is executing its business plan and is moving down the path of commercialization -- see the announcement from this morning, "ClearSign Combustion Corporation Develops Novel Power Amplifier for Cost Effective Implementation of ECC(TM) Technology" - http://yhoo.it/UFnJGm
Matt, mark my words: You are going to get absolutely hammered with your short position. The fact that you're attempting to manipulate a short @ $4/share while taking on unlimited risk to the upside exposes how illogical this whole effort is. I'm not in Uni-Pixel (http://bit.ly/11QcqNH), which also is backed by MDB, but the shorts have been annihilated on that one. As were the naysayers on VirnetX (http://bit.ly/YrMPpY) and Medivation (http://bit.ly/zicQfg), which also have roots to MDB. So, Matt, keep publishing your defamatory pieces, and just know you've been warned.
Why Is Uni-Pixel Falling? [View article]
Dear Clients and Friends,
As the year comes to a close, I’d like to take some time to provide all of you with an update on the MDB universe. I think everyone on Wall Street would agree that this year has certainly seen its ups and downs—through them all, I remain steadfastly optimistic about the companies we have lifted into the public markets, and immensely proud of the investors who have joined us.
To begin, I want to share a brief summary of our investment model, because our belief in that model is what grounds us during these ups and downs in the market.
Our Model
At its root, our model is fairly simple:
1. Find companies with technologies that can be disruptive to very large markets.
2. Validate their technologies through diligence and the opinion of credible third party experts.
3. Help them construct an integrated business and IP strategy to get through development and to the point that large companies publicly validate the technology.
4. Finance the companies at valuations that increase the probability of generating significant returns.
5. Launch the companies into the public markets, both to allow the value of the company to increase with commercial validation and to provide liquidity to shareholders.
Historically, we have seen that when diligence demonstrates that a technology makes sense, large commercial partners usually validate it. The burning question, of course, is, “When?” Unfortunately, it is hard to know the answer to that with any degree of accuracy—macroeconomic, supply chain, strategic and operational factors can all play a role. This is why we fund these companies at valuations that reflect the early-stage nature of the company’s technology and business.
We have found, however, that when that validation does come, the value generally goes higher than anyone expects. In general, we have found that disruptive technologies often trade well above $100M when validated by large commercial entities, and in some cases can trade as high as $1B.
Before that validation point, however, early-stage companies can often face a kind of “valley of doubt.” This is the time in an early-stage company’s lifecycle in which critics—some whose intentions are good, some whose are less so—try to poke holes in something they view as being “too good to be true.” Often, these critics will speak loudly enough to create selling pressure.
This is why we need to do a good job of building faith in our investors—so that this selling pressure doesn’t rattle them. We believe that active communication is the key to building that faith. To that end, we are working with our client companies to help them better communicate their accomplishments to both their investors and Wall Street in general. We are also helping them develop response plans in case their critics come out with spurious attacks. Finally, we will also facilitate our own public diligence calls with noted industry experts, which we have found can also help build faith and quell doubts.
To provide an example hot off of the presses: On December 7th, Uni-Pixel, a company we financed in December 2010, announced it had signed a multi-million dollar license deal with a “major PC manufacturer.” Uni-Pixel’s stock has almost doubled since the announcement. Uni-Pixel is moving out of the “valley of doubt,” and investors who had faith in the company are being rewarded.
Parametric and ClearSign
Of course, some of the companies we have financed have not yet received that validation. In fact, two of the companies we have financed in the past year (Parametric Sound and ClearSign Combustion) recently experienced downward price pressure due to a lack of investor confidence. Both suffered from negative articles published on Seeking Alpha, links to which appeared on reputable sites like Yahoo! Finance and Bloomberg.
The goal of both of these articles was to plant doubt in advance of lock-up expirations to profit from short selling. (Unfortunately, they “worked,” and prices did indeed decline as a result.) To that end, the authors of these articles used words such as “scam” and “fraud” to describe the companies. Of course, we know nothing could be further from the truth, and that both companies have real innovations and management with the highest standards of integrity. Still, when people read these kinds of inflammatory words, they ask themselves: “Could this be true?” We believe this caused panic among investors. (Exacerbating matters were macro trends outside of anyone’s control, including the weakness in the small cap market overall in October and November, and the push by investors to realize capital gains and losses in the face of an uncertain tax environment.)
We want to make clear that these critics have not shaken our faith in these companies. We’ve been in constant contact with management in both cases, and we actually feel more positive about these companies today than when we originally financed them.
• Technology: Both companies have been delivering on their stated goals with the development of the technology; in fact, both have exceeded expectations with respect to technological milestones.
• Validation: Both companies are in active discussions with high-profile commercial partners that would provide the validation that investors seek.
• Risk-adjusted Return: Both companies offer exceptional potential returns to investors, as the valuations are still modest even though the companies have significantly reduced risk since their last financings were completed.
So, as one of my mentors in the business of investing in early stage companies would often say, “Keep the faith!” We know that we will all weather this storm together.
I want to thank you all again for being part of the extended MDB family. We all wish you a safe and happy holiday season, and look forward to having you by our side as we enter 2013.
Warmest regards,
Christopher Marlett
The Future Is CLIR: Why The Shorts Are Wrong About ClearSign Combustion [View article]
The Future Is CLIR: Why The Shorts Are Wrong About ClearSign Combustion [View article]
The Future Is CLIR: Why The Shorts Are Wrong About ClearSign Combustion [View article]
The Future Is CLIR: Why The Shorts Are Wrong About ClearSign Combustion [View article]
The Future Is CLIR: Why The Shorts Are Wrong About ClearSign Combustion [View article]
The Future Is CLIR: Why The Shorts Are Wrong About ClearSign Combustion [View article]
The Future Is CLIR: Why The Shorts Are Wrong About ClearSign Combustion [View article]